Molecular Markers of Early Pancreatic Cancer

p53 Mutations in Human Cancers

Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018

Cancer Statistics, 2005

Jemal, A., Murray, T., Ward, E., Samuels, A., Tiwari, R. C., Ghafoor, A., Feuer, E. J., & Thun, M. J. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.1.10 · Cited by 4,186

Pancreatitis and the Risk of Pancreatic Cancer

Lowenfels, A. B., Maisonneuve, P., Cavallini, G., Ammann, R., Lankisch, P. G., Andersen, J. R., DiMagno, E. P., Andrén‐Sandberg, Å., & Domellöf, L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305203282001 · Cited by 1,753

Phases of Biomarker Development for Early Detection of Cancer

Pepe, M. S., Etzioni, R., Feng, Z., Potter, J. D., Thompson, M. L., Thornquist, M., Winget, M., & Yasui, Y. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.14.1054 · Cited by 1,686

Colorectal carcinoma antigens detected by hybridoma antibodies

Koprowski, H., Steplewski, Z., Mitchell, K. F., Herlyn, M., Herlyn, D., & Fuhrer, P. (1979) · Somatic Cell and Molecular Genetics · doi:10.1007/bf01542654 · Cited by 1,360

MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-β superfamily

Bootcov, M. R., Bauskin, A. R., Valenzuela, S. M., Moore, A. G., Bansal, M., He, X. Y., Zhang, H. P., Donnellan, M., Mahler, S. M., Pryor, K., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11514 · Cited by 1,180

Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma

Caldas, C., Hahn, S. A., da Costa, L. T., Redston, M. S., Schutte, M. E. M., Seymour, A. B., Weinstein, C. L., Hruban, R. H., Yeo, C. J., & Kern, S. E. (1994) · Nature Genetics · doi:10.1038/ng0994-27 · Cited by 1,132

An Illustrated Consensus on the Classification of Pancreatic Intraepithelial Neoplasia and Intraductal Papillary Mucinous Neoplasms

Hruban, R. H., Takaori, K., Klimstra, D. S., Adsay, N. V., Albores-Saavedra, J., Biankin, A. V., Biankin, S. A., Compton, C., Fukushima, N., Furukawa, T., et al. (2004) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000126675.59108.80 · Cited by 1,091

Hereditary Pancreatitis and the Risk of Pancreatic Cancer

Lowenfels, A. B., Maisonneuve, P., DiMagno, E. P., Elitsur, Y., Gates, L. K., Perrault, J., Whitcomb, D. C., & International Hereditary Pancreatitis Study Group (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.6.442 · Cited by 988

Pancreaticoduodenectomy for Cancer of the Head of the Pancreas 201 Patients

Yeo, C. J., Cameron, J. L., Lillemoe, K. D., Sitzmann, J. V., Hruban, R. H., Goodman, S. N., Dooley, W. C., Coleman, J., & Pitt, H. A. (1995) · Annals of Surgery · doi:10.1097/00000658-199506000-00011 · Cited by 945

Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer

Zhang, Z., Bast, R. C., Yu, Y., Li, J., Sokoll, L. J., Rai, A. J., Rosenzweig, J. M., Cameron, B., Wang, Y. Y., Meng, X.-Y., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0746 · Cited by 929

Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer.

Welsh, J. B., Sapinoso, L. M., Su, A. I., Kern, S. G., Wang‐Rodriguez, J., Moskaluk, C. A., Frierson, H. F., & Hampton, G. M. (2001) · PubMed · Cited by 851

Somatic mutations of the mitochondrial genome in human colorectal tumours

Polyák, K., Li, Y., Zhu, H., Christoph Lengauer, C., Willson, J. K. V., Markowitz, S. D., Trush, M. A., Kinzler, K. W., & Vogelstein, B. (1998) · Nature Genetics · doi:10.1038/3108 · Cited by 834

Facile Detection of Mitochondrial DNA Mutations in Tumors and Bodily Fluids

Fliss, M., Usadel, H., Caballero, O. L., Wu, L. J., Buta, M. R., Eleff, S. M., Jen, J., & Sidransky, D. (2000) · Science · doi:10.1126/science.287.5460.2017 · Cited by 821

Prospective Risk of Pancreatic Cancer in Familial Pancreatic Cancer Kindreds

Klein, A. P., Brune, K. A., Petersen, G. M., Goggins, M., Tersmette, A. C., Offerhaus, G. J. A., Griffin, C., Cameron, J. L., Yeo, C. J., Kern, S., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3823 · Cited by 678

Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas.

Goggins, M., Schutte, M. E. M., Lü, J., Moskaluk, C. A., Weinstein, C. L., Petersen, G. M., Yeo, C. J., Jackson, C. E., Lynch, H. T., Hruban, R. H., et al. (1996) · PubMed · Cited by 642

Increased Risk of Pancreatic Cancer in Melanoma-Prone Kindreds withp16INK4Mutations

Goldstein, A. M., Fraser, M. C., Struewing, J. P., Hussussian, C. J., Ranade, K., Zametkin, D. P., Fontaine, L. S., Organic, S. M., Dracopoli, N. C., Clark, W. H., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199510123331504 · Cited by 620

Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments

Baggerly, K., Morris, J. S., & Coombes, K. R. (2004) · Bioinformatics · doi:10.1093/bioinformatics/btg484 · Cited by 607

Untitled work

(1990) · PubMed · Cited by 579

Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer.

Logsdon, C. D., Simeone, D. M., Binkley, C. E., Arumugam, T., Greenson, J. K., Giordano, T. J., Misek, D. E., Kuick, R., & Hanash, S. (2003) · PubMed · Cited by 543

BRCA2 germline mutations in familial pancreatic carcinoma

Hahn, S. A., Greenhalf, B., Ellis, I., Sina-Frey, M., Rieder, H., Korte, B., Gerdes, B., Kress, R., Ziegler, A., Raeburn, J. A., et al. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.3.214 · Cited by 480

Exploration of Global Gene Expression Patterns in Pancreatic Adenocarcinoma Using cDNA Microarrays

Iacobuzio–Donahue, C. A., Maitra, A., Olsen, M. N., Lowe, A. W., van Heek, N. T., Rosty, C., Kim, W., Sato, N., Parker, A. R., Ashfaq, R., et al. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63911-9 · Cited by 471

p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions.

Redston, M. S., Caldas, C., Seymour, A. B., Hruban, R. H., da Costa, L., Yeo, C. J., & Kern, S. E. (1994) · PubMed · Cited by 451

Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach

Canto, M. I., Goggins, M., Yeo, C. J., Griffin, C., Axilbund, J. E., Brune, K., Ali, S. Z., Jagannath, S., Petersen, G. M., Fishman, E. K., et al. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00244-7 · Cited by 448

Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%.

Murphy, K. M., Brune, K. A., Griffin, C. A., Sollenberger, J. E., Petersen, G. M., Bansal, R. K., Hruban, R. H., & Kern, S. E. (2002) · PubMed · Cited by 435

p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma.

Moskaluk, C. A., Hruban, R. H., & Kern, S. E. (1997) · PubMed · Cited by 429

Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies.

Iacobuzio–Donahue, C. A., Ashfaq, R., Maitra, A., Adsay, V. N., Shen-Ong, G. L. C., Berg, K. D., Hollingsworth, M. A., Cameron, J. L., Yeo, C. J., Kern, S. E., et al. (2003) · PubMed · Cited by 415

Hypermethylation of multiple genes in pancreatic adenocarcinoma.

Ueki, T., Toyota, M., Sohn, T. A., Yeo, C. J., Issa, J. J., Hruban, R. H., & Goggins, M. (2000) · PubMed · Cited by 407

AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma

DiMagno, E. P., Reber, H. A., & Tempero, M. A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70298-2 · Cited by 402

Cyclooxygenase Inhibitors Regulate the Expression of a TGF-β Superfamily Member That Has Proapoptotic and Antitumorigenic Activities

Baek, S. J., Kim, K. S., Nixon, J. B., Wilson, L. C., & Eling, T. E. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.4.901 · Cited by 402

Clinical usefulness of carbohydrate antigen 19‐9 as a screening test for pancreatic cancer in an asymptomatic population

KIM, J., Lee, K. T., Lee, J. K., Paik, S. W., Rhee, P., & Choi, K. W. (2004) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2004.03219.x · Cited by 395

Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer

Brentnall, T. A., Bronner, M. P., Byrd, D. R., Haggitt, R. C., & Kimmey, M. B. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-4-199908170-00003 · Cited by 391

Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray.

Han, H., Bearss, D. J., Browne, L. W., Calaluce, R., Nagle, R. B., & Hoff, D. D. V. (2002) · PubMed · Cited by 380

Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia.

Caldas, C., Hahn, S. A., Hruban, R. H., Redston, M. S., Yeo, C. J., & Kern, S. E. (1994) · PubMed · Cited by 377

Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma.

Tada, M., Omata, M., Kawai, S., Saisho, H., Ohto, M., Saiki, R. K., & Sninsky, J. J. (1993) · PubMed · Cited by 375

Mesothelin-specific CD8+ T Cell Responses Provide Evidence of In Vivo Cross-Priming by Antigen-Presenting Cells in Vaccinated Pancreatic Cancer Patients

Thomas, A. M., SANTARSIERO, L., Lutz, E. R., Armstrong, T. D., Chen, Y.-C., Huang, L.-Q., Laheru, D. A., Goggins, M., Hruban, R. H., & Jaffee, E. M. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031435 · Cited by 347

Protein Expression Profiles in Pancreatic Adenocarcinoma Compared with Normal Pancreatic Tissue and Tissue Affected by Pancreatitis as Detected by Two-Dimensional Gel Electrophoresis and Mass Spectrometry

Shen, J., Person, M. D., Zhu, J., Abbruzzese, J. L., & Li, D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-3262 · Cited by 337

Evaluation of Serum Protein Profiling by Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometry for the Detection of Prostate Cancer: I. Assessment of Platform Reproducibility

Semmes, O. J., Feng, Z., Adam, B.-L., Bañez, L. L., Bigbee, W. L., Campos, D. D., Cazares, L. H., Chan, D. W., Grizzle, W. E., Izbicka, E., et al. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.038950 · Cited by 336

Detecting Colorectal Cancer in Stool With the Use of Multiple Genetic Targets

Dong, S. M., Traverso, G., Johnson, C., Geng, L., Favis, R., Boynton, K. A., Hibi, K., Goodman, S. N., D’Allessio, M., Paty, P. B., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.11.858 · Cited by 334

Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays.

Sato, N., Fukushima, N., Maitra, A., Matsubayashi, H., Yeo, C. J., Cameron, J. L., Hruban, R. H., & Goggins, M. (2003) · PubMed · Cited by 328

Intraductal papillary mucinous neoplasms of the pancreas: an increasingly recognized clinicopathologic entity

Sohn, T. A., Yeo, C. J., Cameron, J. L., Iacobuzio-Donahue, C. A., Hruban, R. H., & Lillemoe, K. D. (2001) · Annals of Surgery · doi:10.1097/00000658-200109000-00005 · Cited by 311

Untitled work

(2001) · PubMed · Cited by 309

Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer.

Tersmette, A. C., Petersen, G. M., Offerhaus, G. J. A., Falatko, F. C., Brune, K. A., Goggins, M., Rozenblum, E., Wilentz, R. E., Yeo, C. J., Cameron, J. L., et al. (2001) · PubMed · Cited by 307

Frequent hypomethylation of multiple genes overexpressed in pancreatic ductal adenocarcinoma.

Sato, N., Maitra, A., Fukushima, N., van Heek, N. T., Matsubayashi, H., Iacobuzio–Donahue, C. A., Rosty, C., & Goggins, M. (2003) · PubMed · Cited by 304

Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology.

Rosty, C., Christa, L., Kuzdzal, S. A., Baldwin, W. M., ZAHURAK, M. L., Carnot, F., Chan, D. W., Canto, M. I., Lillemoe, K. D., Cameron, J. L., et al. (2002) · PubMed · Cited by 292

Signal in Noise: Evaluating Reported Reproducibility of Serum Proteomic Tests for Ovarian Cancer

Baggerly, K., Morris, J. S., Edmonson, S. R., & Coombes, K. R. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji008 · Cited by 291

Cloning and Characterization of a Novel Member of the Transforming Growth Factor-β/Bone Morphogenetic Protein Family

Paralkar, V. M., Vail, A. L., GRASSER, W. A., Brown, T. A., Xu, H., Vukičević, S., Ke, H. Z., Qi, H., Owen, T. A., & Thompson, D. D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13760 · Cited by 289

High-resolution characterization of the pancreatic adenocarcinoma genome

Aguirre, A. J., Brennan, C. W., Bailey, G., Sinha, R., Feng, B., Leo, C., Zhang, Y., Zhang, J., Gans, J. D., Bardeesy, N. M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402932101 · Cited by 277

Serum Diagnosis of Pancreatic Adenocarcinoma Using Surface-Enhanced Laser Desorption and Ionization Mass Spectrometry

Koopmann, J., Zhang, Z., White, N., Rosenzweig, J. M., Fedarko, N. S., Jagannath, S. B., Canto, M. I., Yeo, C. J., Chan, D. W., & Goggins, M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1167-3 · Cited by 277

Serum Macrophage Inhibitory Cytokine 1 as a Marker of Pancreatic and Other Periampullary Cancers

Koopmann, J., Buckhaults, P., Brown, D. A., ZAHURAK, M. L., Sato, N., Fukushima, N., Sokoll, L. J., Chan, D. W., Yeo, C. J., Hruban, R. H., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0165 · Cited by 274

SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor–stromal interactions

Sato, N., Fukushima, N., Maehara, N., Matsubayashi, H., Koopmann, J., Su, G. H., Hruban, R. H., & Goggins, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206807 · Cited by 273

STK11/LKB1 Peutz-Jeghers Gene Inactivation in Intraductal Papillary-Mucinous Neoplasms of the Pancreas

Sato, N., Rosty, C., Jansen, M., Fukushima, N., Ueki, T., Yeo, C. J., Cameron, J. L., Iacobuzio–Donahue, C. A., Hruban, R. H., & Goggins, M. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63053-2 · Cited by 268

MIC-1 serum level and genotype: associations with progress and prognosis of colorectal carcinoma.

Brown, D. A., Ward, R. L., Buckhaults, P., Liu, T., Romans, K. E., Hawkins, N. J., Bauskin, A. R., Kinzler, K. W., Vogelstein, B., & Breit, S. N. (2003) · PubMed · Cited by 265

Lessons from Controversy: Ovarian Cancer Screening and Serum Proteomics

Ransohoff, D. F. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji054 · Cited by 265

Fanconi anemia gene mutations in young-onset pancreatic cancer.

van der Heijden, M. S., Yeo, C. J., Hruban, R. H., & Kern, S. E. (2003) · PubMed · Cited by 262

Genome-wide cDNA microarray analysis of gene expression profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity by laser microdissection

Nakamura, T., Furukawa, Y., Nakagawa, H., Tsunoda, T., Ohigashi, H., Murata, K., Ishikawa, O., Ohgaki, K., Kashimura, N., Miyamoto, M., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207392 · Cited by 261

The Human MitoChip: A High-Throughput Sequencing Microarray for Mitochondrial Mutation DetectionPreprint

Maitra, A., Cohen, Y., Gillespie, S. E. D., Mambo, E., Fukushima, N., Hoque, M. O., Shah, N., Goggins, M., Califano, J., Sidransky, D., et al. (2004) · Genome Research · doi:10.1101/gr.2228504 · Cited by 237

Identification of a mononucleotide repeat as a major target for mitochondrial DNA alterations in human tumors.

Sánchez‐Céspedes, M., Parrella, P., Nomoto, S., Cohen, D., Xiao, Y. Q., Esteller, M., Jerónimo, C., Jordan, R. C. K., Nicol, T. L., Koch, W. M., et al. (2001) · PubMed · Cited by 236

PLAB, a novel placental bone morphogenetic protein

Hromas, R., Hufford, M. B., Sutton, J., Xu, D., Li, Y., & Lu, L. (1997) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(97)00122-x · Cited by 233

Aberrant Methylation of Preproenkephalin and p16 Genes in Pancreatic Intraepithelial Neoplasia and Pancreatic Ductal Adenocarcinoma

Fukushima, N., Sato, N., Ueki, T., Rosty, C., Walter, K., Wilentz, R. E., Yeo, C. J., Hruban, R. H., & Goggins, M. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61104-2 · Cited by 225

Expression profiling of microdissected pancreatic adenocarcinomas

Crnogorac‐Jurcevic, T., Efthimiou, E., Nielsen, T. O., Loader, J., Terris, B., Stamp, G., Baron, A., Scarpa, A., & Lemoine, N. R. (2002) · Oncogene · doi:10.1038/sj.onc.1205570 · Cited by 225

p53 Mutations and Survival in Stage I Non-Small-Cell Lung Cancer: Results of a Prospective Study

Ahrendt, S. A., Hu, Y. C., Buta, M. R., McDermott, M., Benoit, N. E., Yang, S. C., Wu, L., & Sidransky, D. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.13.961 · Cited by 220

Detection of mitochondrial DNA mutations in pancreatic cancer offers a "mass"-ive advantage over detection of nuclear DNA mutations.

Jones, J. B., Song, J. J., Hempen, P. M., Parmigiani, G., Hruban, R. H., & Kern, S. E. (2001) · PubMed · Cited by 219

Gene Expression Profiling Identifies Genes Associated with Invasive Intraductal Papillary Mucinous Neoplasms of the Pancreas

Sato, N., Fukushima, N., Maitra, A., Iacobuzio–Donahue, C. A., van Heek, N. T., Cameron, J. L., Yeo, C. J., Hruban, R. H., & Goggins, M. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63178-1 · Cited by 208

A prospective study of K-ras mutations in the plasma of pancreatic cancer patients.

Mulcahy, H. E., Lyautey, J., Lederrey, C., Chen, X. Q., Anker, P., Alstead, E. M., Ballinger, A., Farthing, M. J. G., & Stroun, M. (1998) · PubMed · Cited by 205

Comprehensive Proteomic Analysis of Human Pancreatic Juice

Grønborg, M., Bunkenborg, J., Kristiansen, T. Z., Jensen, O. N., Yeo, C. J., Hruban, R. H., Maitra, A., Goggins, M., & Pandey, A. (2004) · Journal of Proteome Research · doi:10.1021/pr0499085 · Cited by 197

Evaluation of Osteopontin as Biomarker for Pancreatic Adenocarcinoma

Koopmann, J., Fedarko, N. S., Jain, A., Maitra, A., Iacobuzio–Donahue, C. A., Rahman, A., Hruban, R. H., Yeo, C. J., & Goggins, M. (2004) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.487.13.3 · Cited by 195

Genetics of Pancreatic Cancer

Hruban, R. H., Petersen, G. M., Ha, P. K., & Kern, S. E. (1998) · Surgical Oncology Clinics of North America · doi:10.1016/s1055-3207(18)30282-5 · Cited by 194

p53 and K-RAS alterations in pancreatic epithelial cell lesions.

Kalthoff, H., Schmiegel, W., Röder, C., Kasche, D., Schmidt, A., Lauer, G., Thiele, H. G., Honold, G., Pantel, K., & Riethmüller, G. (1993) · PubMed · Cited by 185

Role of tumour markers, cytogenetics

Lamerz, R. (1999) · Annals of Oncology · doi:10.1093/annonc/10.suppl_4.s145 · Cited by 178

Application of laser capture microdissection combined with two‐dimensional electrophoresis for the discovery of differentially regulated proteins in pancreatic ductal adenocarcinoma

Shekouh, A., Thompson, C. C., Prime, W., Campbell, F., Hamlett, J., Herrington, C. S., Lemoine, N. R., Crnogorac‐Jurcevic, T., Buechler, M. W., Friess, H., et al. (2003) · PROTEOMICS · doi:10.1002/pmic.200300466 · Cited by 173

Epigenetic inactivation of TFPI-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma

Sato, N., Parker, A. R., Fukushima, N., Miyagi, Y., Iacobuzio–Donahue, C. A., Eshleman, J. R., & Goggins, M. (2004) · Oncogene · doi:10.1038/sj.onc.1208050 · Cited by 171

Plasma Protein Profiling for Diagnosis of Pancreatic Cancer Reveals the Presence of Host Response Proteins

Koomen, J. M., Shih, L.-C. N., Coombes, K. R., Li, D., Xiao, L.-C., Fidler, I. J., Abbruzzese, J. L., & Kobayashi, R. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.1110.11.3 · Cited by 164

Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system.

Lee, D. H., Yang, Y. D., Lee, S. J., Kim, K. Y., Koo, T. H., Shin, S. M., Song, K. S., Lee, Y. H., Kim, Y. J., Lee, J. J., et al. (2003) · PubMed · Cited by 161

Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features.

Yamada, T., Nakamori, S., Ohzato, H., Oshima, S., Aoki, T., HIGAKI, N., Sugimoto, K., Akagi, K., Fujiwara, Y., Nishisho, I., et al. (1998) · PubMed · Cited by 159

Mitochondrial D-loop mutations as clonal markers in multicentric hepatocellular carcinoma and plasma.

Nomoto, S., Yamashita, K., Koshikawa, K., Nakao, A., & Sidransky, D. (2002) · PubMed · Cited by 159

Gene Expression Profiling of Tumor–Stromal Interactions between Pancreatic Cancer Cells and Stromal Fibroblasts

Sato, N., Maehara, N., & Goggins, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0677 · Cited by 158

Proteomic Profiling of Pancreatic Cancer for Biomarker Discovery

Chen, R., Pan, S., Brentnall, T. A., & Aebersold, R. H. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r500004-mcp200 · Cited by 152

Genomic DNA-Chip Hybridization Reveals a Higher Incidence of Genomic Amplifications in Pancreatic Cancer than Conventional Comparative Genomic Hybridization and Leads to the Identification of Novel Candidate Genes

Holzmann, K., Kohlhammer, H., Schwäenen, C., Weßendorf, S., Kestler, H. A., Schwoerer, A., Rau, B., Radlwimmer, B., Döhner, H., Lichter, P., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0431 · Cited by 142

Early detection of pancreatic carcinoma

Rosty, C., & Goggins, M. (2002) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(01)00007-7 · Cited by 141

Aberrant methylation of CpG islands in intraductal papillary mucinous neoplasms of the pancreas

Sato, N., Ueki, T., Fukushima, N., Iacobuzio–Donahue, C. A., Hruban, R. H., Goggins, M., Yeo, C. J., & Cameron, J. L. (2002) · Gastroenterology · doi:10.1053/gast.2002.34160 · Cited by 139

Aberrant methylation of suppressor of cytokine signalling-1 (SOCS-1) gene in pancreatic ductal neoplasms

Fukushima, N., Sato, N., Sahin, F., Su, G. H., Hruban, R. H., & Goggins, M. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601039 · Cited by 132

Methylation of cyclin D2 is observed frequently in pancreatic cancer but is also an age-related phenomenon in gastrointestinal tissues.

Matsubayashi, H., Sato, N., Fukushima, N., Yeo, C. J., Walter, K., Brune, K. A., Şahin, F., Hruban, R. H., & Goggins, M. (2003) · PubMed · Cited by 130

LigAmp for sensitive detection of single-nucleotide differences

Shi, C., Eshleman, S. H., Jones, D. C., Fukushima, N., Li, H., Parker, A. R., Yeo, C. J., Hruban, R. H., Goggins, M., & Eshleman, J. R. (2004) · Nature Methods · doi:10.1038/nmeth713 · Cited by 127

Invasion-specific genes in malignancy: serial analysis of gene expression comparisons of primary and passaged cancers.

Ryu, B., Jones, J., Hollingsworth, M. A., Hruban, R. H., & Kern, S. E. (2001) · PubMed · Cited by 119

Actions of heparin that may affect the malignant process

Engelberg, H. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990115)85:2 · Cited by 119

American Gastroenterological Association medical position statement: Epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma

(1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70297-0 · Cited by 119

Effects of 5-Aza-2'-deoxycytidine on Matrix Metalloproteinase Expression and Pancreatic Cancer Cell Invasiveness

Sato, N., Maehara, N., Su, G. H., & Goggins, M. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.4.327 · Cited by 118

Human cDNA Encoding a Novel TGF- Superfamily Protein Highly Expressed in Placenta

Yokoyama-Kobayashi, M., Saeki, M., Sekine, S., & Kato, S. (1997) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021798 · Cited by 116

Genome-wide aberrations in pancreatic adenocarcinoma

Nowak, N. J., Gaile, D. P., Conroy, J. M., McQuaid, D., Cowell, J. K., Carter, R. L., Goggins, M., Hruban, R. H., & Maitra, A. (2005) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2005.01.009 · Cited by 115

Identifying markers for pancreatic cancer by gene expression analysis.

Zhou, W., Sokoll, L. J., Bruzek, D. J., Zhang, L., Velculescu, V. E., Goldin, S. B., Hruban, R. H., Kern, S. E., Hamilton, S. R., Chan, D. W., et al. (1998) · PubMed · Cited by 115

Aberrant Methylation of the 5' CpG Island of TSLC1 Is Common in Pancreatic Ductal Adenocarcinoma and Is First Manifest in High-Grade PanINs

Jansen, M., Fukushima, N., Rosty, C., Kim, W., Altink, R., van Heek, N. T., Hruban, R. H., Offerhaus, G. J. A., & Goggins, M. (2002) · Cancer Biology & Therapy · doi:10.4161/cbt.84 · Cited by 113

Novel Markers of Pancreatic Adenocarcinoma in Fine-Needle Aspiration: Mesothelin and Prostate Stem Cell Antigen Labeling Increases Accuracy in Cytologically Borderline Cases

McCarthy, D. M., Maitra, A., Argani, P., Rader, A. E., Faigel, D. O., van Heek, N. T., Hruban, R. H., & Wilentz, R. E. (2003) · Applied immunohistochemistry & molecular morphology · doi:10.1097/00129039-200309000-00006 · Cited by 110

Characterization of gene expression in mucinous cystic neoplasms of the pancreas using oligonucleotide microarrays

Fukushima, N., Sato, N., Prasad, N. B., Leach, S. D., Hruban, R. H., & Goggins, M. (2004) · Oncogene · doi:10.1038/sj.onc.1208117 · Cited by 108

Diagnosing Pancreatic Cancer Using Methylation Specific PCR Analysis

Fukushima, N., Walter, K., Ueki, T., Sato, N., Matsubayashi, H., Cameron, J. L., Hruban, R. H., Canto, M. I., Yeo, C. J., & Goggins, M. (2003) · Cancer Biology & Therapy · doi:10.4161/cbt.183 · Cited by 103

Prognostic significance of young age in breast cancer

Yıldırım, E., Dalğıç, T., & Berberoğlu, U. (2000) · Journal of Surgical Oncology · doi:10.1002/1096-9098(200008)74:4 · Cited by 100

Diagnosis of Pancreatic Cancer Using Serum Proteomic Profiling

Bhattacharyya, S., Siegel, E. R., Petersen, G. M., Chari, S. T., Suva, L. J., & Haun, R. S. (2004) · Neoplasia · doi:10.1593/neo.04262 · Cited by 90

Prognostic factors in ductal pancreatic cancer

Yeo, C. J., & Cameron, J. L. (1998) · Langenbeck s Archives of Surgery · doi:10.1007/s004230050104 · Cited by 89

Importance of Communication Between Producers and Consumers of Publicly Available Experimental Data

Liotta, L. A., Lowenthal, M. S., Mehta, A. I., Conrads, T. P., Veenstra, T. D., Fishman, D. A., & Petricoin, E. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji053 · Cited by 88

Use of microsatellite marker loss of heterozygosity in accurate diagnosis of pancreaticobiliary malignancy from brush cytology samples

Khalid, A., Pal, R., Sasatomi, E., Swalsky, P., Slivka, A., Whitcomb, D., & Finkelstein, S. (2004) · Gut · doi:10.1136/gut.2004.039784 · Cited by 86

Differentially expressed genes in pancreatic ductal adenocarcinomas identified through serial analysis of gene expression

Hustinx, S. R., Cao, D., Maitra, A., Sato, N., Martin, S., Sudhir, D., Iacobuzio–Donahue, C. A., Cameron, J. L., Yeo, C. J., Kern, S. E., et al. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.12.1238 · Cited by 77

GDF-15/MIC-1 a novel member of the TGF-ß superfamily

Strelau, J., Bottner, M. B., Lingor, P., Suter‐Crazzolara, C., Galter, D., Jászai, J., Sullivan, A. M., Schober, A., KRIEGLSTEIN, K. G., & Unsicker, K. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6301-6_18 · Cited by 69

Gene expression alterations in the non-neoplastic parenchyma adjacent to infiltrating pancreatic ductal adenocarcinoma

Fukushima, N., Koopmann, J., Sato, N., Prasad, N. B., Carvalho, R., Leach, S. D., Hruban, R. H., & Goggins, M. (2005) · Modern Pathology · doi:10.1038/modpathol.3800337 · Cited by 67

Elevated levels of telomerase activity in malignant pheochromocytoma

Kubota, Y., Nakada, T., Sasagawa, I., Yanai, H., & Itoh, K. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980101)82:1 · Cited by 65

Identification of novel highly expressed genes in pancreatic ductal adenocarcinomas through a bioinformatics analysis of expressed sequence tags

Cao, D., Hustinx, S. R., Sui, G., Bala, P., Sato, N., Martin, S., Maitra, A., Murphy, K. M., Cameron, J. L., Yeo, C. J., et al. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.11.1175 · Cited by 60

Aberrant CpG island methylation in cancer cell lines arises in the primary cancers from which they were derived

Ueki, T., Walter, K., Skinner, H. G., Jaffee, E. M., Hruban, R. H., & Goggins, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205275 · Cited by 57

Intraductal Papillary Mucinous Neoplasm: Did it exist prior to 1980?

Tollefson, M. K., Libsch, K. D., Sarr, M. G., Chari, S. T., DiMagno, E. P., Urrutia, R. A., & Smyrk, T. C. (2003) · Pancreas · doi:10.1097/00006676-200304000-00023 · Cited by 54

A highly sensitive and quantitative telomerase activity assay with pancreatic juice is useful for diagnosis of pancreatic carcinoma without problems due to polymerase chain reaction inhibitors

Ohuchida, K., Mizumoto, K., Ishikawa, N., Sato, N., Nagai, E., Yamaguchi, K., Takaishi, H., Ide, T., & Tanaka, M. (2004) · Cancer · doi:10.1002/cncr.20649 · Cited by 39

A new indication for pancreas transplantation: high grade pancreatic dysplasia

Charpentier, K. P., Brentnall, T. A., Bronner, M. P., Byrd, D. R., & Marsh, C. L. (2004) · Clinical Transplantation · doi:10.1111/j.1399-0012.2004.00110.x · Cited by 27

Inhibiting Tyrosine Kinases: Successes and Limitations

Arteaga, C. L. (2003) · Cancer Biology & Therapy · doi:10.4161/cbt.206 · Cited by 20

Evaluation of osteopontin as biomarker for pancreatic adenocarcinoma

Koopmann, J., Fedarko, N. S., Jain, A., Maitra, A., Iacobuzio–Donahue, C. A., Yeo, C. J., Hruban, R. H., & Goggins, M. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)82230-8 · Cited by 16

Tumour markers in gastrointestinal cancers--EGTM recommendations. European Group on Tumour Markers.

(1999) · PubMed · Cited by 15

Screening for Pancreatic Neoplasia in Asymptomatic High Risk Individuals: A Prospective, Controlled Study

Canto, M. I., Goggins, M., Jagannath, S. B., Kantsevoy, S. V., Griffin, C. A., Axilbund, J. E., Brune, K. A., Petersen, G. M., Fishman, E. K., Yeo, C. J., et al. (2004) · Gastrointestinal Endoscopy · doi:10.1016/s0016-5107(04)00482-1 · Cited by 4

Aberrant type I and type III collagen gene expression in human breast cancerin vivo

Kauppila, S., Stenbäck, F., Risteli, J., Jukkola, A., & Risteli, L. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(1998110)186:3

Sarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic Cancer

Tan, B. H. L., Birdsell, L., Martin, L., Baracos, V. E., & Fearon, K. C. H. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1525 · Cited by 656

Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development

Gironella, M., Seux, M., Xie, M.-J., Cano, C. E., Tomasini, R., Gommeaux, J., Garcia, S., Nowak, J., Yeung, M. L., Jeang, K., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703942104 · Cited by 548

Early detection of pancreatic cancer

Pereira, S. P., Oldfield, L., Ney, A., Hart, P. A., Keane, M. G., Pandol, S. J., Li, D., Greenhalf, W., Jeon, C. Y., Koay, E. J., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30416-9 · Cited by 482

Glycans as cancer biomarkers

Adamczyk, B., Tharmalingam, T., & Rudd, P. M. (2011) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.12.001 · Cited by 481

Biological functions of fucose in mammals

Schneider, M., Al-Shareffi, E., & Haltiwanger, R. S. (2017) · Glycobiology · doi:10.1093/glycob/cwx034 · Cited by 432

Identifying Molecular Markers for the Early Detection of Pancreatic Neoplasia

Goggins, M. (2007) · Seminars in Oncology · doi:10.1053/j.seminoncol.2007.05.003 · Cited by 96

[Towards the identification of new markers of pancreatic cancer by gene expression analysis].

Rosty, C. (2004) · PubMed · Cited by 7

Diagnostic and Therapeutic Response Markers

Lennon, A. M., & Goggins, M. (2009) · Springer eBooks · doi:10.1007/978-0-387-77498-5_28 · Cited by 13

Expression Profiling of Pancreatic Ductal Adenocarcinoma

Iacobuzio–Donahue, C. A., & Hruban, R. H. (2003) · doi:10.1007/978-1-59259-386-6_14 · Cited by 1

Early diagnosis of pancreatic cancer

Xu, L., & Xiaozhong, G. (2016) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.3969/j.issn.1001-5256.2016.05.008